Volume 89 Issue 19 | p. 25 | Concentrates
Issue Date: May 9, 2011

Yale Enters Deals With Biotech Firms

Department: Business, Education
Keywords: biopharmaceuticals, collaboration

Yale University has signed two collaborations to help advance drug candidates in development. Yale researchers will work with Durham, N.C.-based Icagen and Pfizer to explore investigational compounds targeting sodium channels associated with pain. In an alliance with Switzerland’s Debiopharm, university researchers will help develop inhibitors that target a fundamental inflammatory disease pathway. The partners hope to advance Debiopharm’s Debio 1036 program through preclinical and clinical development.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment